Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomea Fusion, Inc.

1.63
+0.03502.20%
Volume:771.72K
Turnover:1.26M
Market Cap:92.66M
PE:-0.46
High:1.70
Open:1.64
Low:1.59
Close:1.59
Loading ...

Biomea Fusion price target lowered to $10 from $30 at Scotiabank

TIPRANKS
·
06 Aug

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
06 Aug

Biomea Fusion Inc : Scotiabank Cuts Target Price to $10 From $30

THOMSON REUTERS
·
06 Aug

Biomea Fusion (BMEA) Gets a Buy from Oppenheimer

TIPRANKS
·
06 Aug

Biomea Fusion Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
06 Aug

Biomea Fusion Q2 net loss narrows to $20.7 mln

Reuters
·
06 Aug

BRIEF-Biomea Fusion Inc Files For Mixed Shelf Of Up To $300 Million – SEC Filing

Reuters
·
06 Aug

Biomea Fusion Q2 EPS $(0.51) Beats $(0.54) Estimate

Benzinga
·
06 Aug

Biomea Fusion reports Q2 EPS (51c), consensus (51c)

TIPRANKS
·
06 Aug

Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights

GlobeNewswire
·
06 Aug

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
04 Aug

Biomea Fusion Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
30 Jul

Biomea Fusion Inc. Files Initial Statement of Beneficial Ownership for Director Julianne Averill

Reuters
·
25 Jul

Biomea Fusion Appoints Julianne Averill to Its Board of Directors

THOMSON REUTERS
·
24 Jul

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
22 Jul

Biomea Fusion price target lowered to $9 from $22 at Citi

TIPRANKS
·
16 Jul

Biomea Fusion’s BMF-219 Study Update: Implications for Investors

TIPRANKS
·
04 Jul

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
24 Jun

Biomea Fusion Inc. Unveils Promising Data for Icovamenib, Showcasing Enhanced Glycemic Control and Weight Loss in Type 2 Diabetes Trial at ADA 2025

Reuters
·
23 Jun

Biomea Fusion Inc. Files Prospectus for $37.1 Million Underwritten Offering of Common Stock and Warrants

Reuters
·
21 Jun